Allergic Rhinitis Clinical Trial
— AR-GTVerified date | October 2011 |
Source | China Medical University Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | Taiwan: Institutional Review Board |
Study type | Observational |
Allergic rhinitis is a complex chronic inflammatory disease, it always presents with nasal
obstruction, nasal itching, sneezing and runny nose. Whether in adults or children, rhinitis
is a complex disease. The prevalence of allergic rhinitis in Taiwan is about 24-29%. Taiwan
is a developing country. It is a hot and humid country. In developing countries,
industrialization, air pollution makes the constantly increasing number of patients with
rhinitis. Penghu in 1994 for children aged 7 to 14 by the study found that among 7599
people, 1766 people have allergic rhinitis, about 23.2%. Allergic rhinitis is a complex
chronic disease. So, it become a diagnostic challenge, its prevalence always underestimated.
The prevalence of rhinitis has increased in recent years. The phenomenon of underestimate is
caused by variety of personal and environmental factors. Allergic rhinitis had increased
direct and indirect social and economic burden.
Geographic tongue is a benign tongue performance. Geographic tongue has been reported their
relevance to allergy. Geographic tongue is a chronic tongue situation. The causes of
geographic tongue still remains unknown. Allergic rhinitis is a diagnostic challenge to
clinicians. The investigators hope that geographic tongue could play a role in the
diagnostic of allergic rhinitis. The prevalence of geographic tongue in the United States is
about 1.8%, white Americans and Mexicans have a higher incidence rate. This study will
investigate the relevance between allergic rhinitis and geographic tongue. The investigators
will analyze the relevant gender, age, severity of inspection reports. The research results
wound provide an important reference to the diagnosis of allergic rhinitis.
Status | Recruiting |
Enrollment | 300 |
Est. completion date | September 2012 |
Est. primary completion date | March 2012 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | 20 Years to 89 Years |
Eligibility |
Inclusion Criteria: - rhinitis and non-rhinitis patients - willing to complete the study - no limitation of tongue movement Exclusion Criteria: - more than 90 years old or younger than 20 years old - unable to complete the study |
Observational Model: Case Control, Time Perspective: Prospective
Country | Name | City | State |
---|---|---|---|
Taiwan | China Medical University Hospital | Taichung |
Lead Sponsor | Collaborator |
---|---|
China Medical University Hospital |
Taiwan,
Masferrer E, Jucgla A. Images in clinical medicine. Geographic tongue. N Engl J Med. 2009 Nov 12;361(20):e44. doi: 10.1056/NEJMicm0810145. — View Citation
Miloglu O, Göregen M, Akgül HM, Acemoglu H. The prevalence and risk factors associated with benign migratory glossitis lesions in 7619 Turkish dental outpatients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009 Feb;107(2):e29-33. doi: 10.1016/j.tri — View Citation
Reamy BV, Derby R, Bunt CW. Common tongue conditions in primary care. Am Fam Physician. 2010 Mar 1;81(5):627-34. Review. — View Citation
Shulman JD, Carpenter WM. Prevalence and risk factors associated with geographic tongue among US adults. Oral Dis. 2006 Jul;12(4):381-6. — View Citation
Ugar-Cankal D, Denizci S, Hocaoglu T. Prevalence of tongue lesions among Turkish schoolchildren. Saudi Med J. 2005 Dec;26(12):1962-7. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Number of participants with Adverse Events | 8th month | Yes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05080322 -
Efficacy and Safety of On-demand and Continuous Administration of Nasal Spray in the Treatment of Allergic Rhinitis
|
Phase 4 | |
Recruiting |
NCT06028490 -
A Study of IL4Rα Monoclonal Antibody in Patients With Uncontrolled Seasonal Allergic Rhinitis.
|
Phase 2 | |
Completed |
NCT04388358 -
Traditional Chinese Medicine for the Treatment of Perennial Allergic Rhinitis on Gut Microbiota and Immune-modulation
|
N/A | |
Recruiting |
NCT04202263 -
Assessment of Suppression of Cutaneous Allergic Responses and Pruritis by Topical Minocycline
|
Phase 2 | |
Completed |
NCT04078009 -
Standardising Nasal Allergen Challenge in Adult With Hay Fever
|
N/A | |
Completed |
NCT03644680 -
Changes in Adaptive Immune Responses and Effector Cell Responses Upon Nasal Allergen Exposure - a Pilot Study
|
N/A | |
Completed |
NCT04541004 -
Adolescent Mite Allergy Safety Evaluation
|
Phase 3 | |
Recruiting |
NCT05378594 -
HDM and Silver Birch NAC Standardisation
|
N/A | |
Not yet recruiting |
NCT05684380 -
Efficacy and Safety of MAZ-101 in the Treatment of Persistent Allergic Rhinitis (PER)
|
Phase 3 | |
Completed |
NCT02943720 -
ATIBAR - Efficacy and Safety of Two Doses of AllerT in Patients Allergic to Birch Pollen
|
Phase 2 | |
Not yet recruiting |
NCT01014325 -
Safety and Efficacy Study With Allergen Extracts of House Dust Mites for Specific Sublingual Immunotherapy
|
Phase 3 | |
Completed |
NCT02910401 -
Clinical Response to Rhinovirus Challenge
|
Phase 2 | |
Completed |
NCT02556801 -
Efficacy and Safety of SUBLIVAC Phleum for Immunotherapy of Grass Pollen-Allergy
|
Phase 2 | |
Not yet recruiting |
NCT02233426 -
Effect of Hypertonic Solutions on Allergic Rhinitis Patients
|
N/A | |
Completed |
NCT02352168 -
Airway Inflammation in Children With Allergic Rhinitis and Intervention
|
N/A | |
Completed |
NCT01918956 -
PURETHAL Birch RUSH Study
|
Phase 4 | |
Completed |
NCT01946035 -
Alpha-Blockers in Allergic Rhinitis (MAN 01)
|
Phase 4 | |
Completed |
NCT01682070 -
SUBLIVAC FIX Phleum Pratense DT/DRF
|
Phase 2 | |
Completed |
NCT01438463 -
PURETHAL® Mites Dose Range Finding Study in Patients With Persistent Allergic Rhinitis/Rhinoconjunctivitis
|
Phase 2 | |
Completed |
NCT01439815 -
An Allergen BioCube (ABC) Study Evaluating the Efficacy of Fluticasone Propionate Nasal Spray Compared to Placebo
|
Phase 4 |